120 related articles for article (PubMed ID: 1725900)
21. Relationship between cyclic guanosine 3':5'-monophosphate formation and relaxation of coronary arterial smooth muscle by glyceryl trinitrate, nitroprusside, nitrite and nitric oxide: effects of methylene blue and methemoglobin.
Gruetter CA; Gruetter DY; Lyon JE; Kadowitz PJ; Ignarro LJ
J Pharmacol Exp Ther; 1981 Oct; 219(1):181-6. PubMed ID: 6270297
[TBL] [Abstract][Full Text] [Related]
22. Endothelium-dependent and independent relaxation of the rat aorta by cyclic nucleotide phosphodiesterase inhibitors.
Komas N; Lugnier C; Stoclet JC
Br J Pharmacol; 1991 Oct; 104(2):495-503. PubMed ID: 1665741
[TBL] [Abstract][Full Text] [Related]
23. Role of nitric oxide and guanosine 3',5'-cyclic monophosphate in mediating nonadrenergic, noncholinergic relaxation in guinea-pig pulmonary arteries.
Liu SF; Crawley DE; Rohde JA; Evans TW; Barnes PJ
Br J Pharmacol; 1992 Nov; 107(3):861-6. PubMed ID: 1335345
[TBL] [Abstract][Full Text] [Related]
24. Effect of sodium-potassium pump inhibitors and membrane-depolarizing agents on sodium nitroprusside-induced relaxation and cyclic guanosine monophosphate accumulation in rat aorta.
Rapoport RM; Schwartz K; Murad F
Circ Res; 1985 Jul; 57(1):164-70. PubMed ID: 2408779
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of the action of nitric oxide prodrugs by pyocyanin: mechanistic studies.
Hussain AS; Bozinovski J; Maurice DH; McLaughlin BE; Marks GS; Brien JF; Nakatsu K
Can J Physiol Pharmacol; 1997 May; 75(5):398-406. PubMed ID: 9250373
[TBL] [Abstract][Full Text] [Related]
26. In vitro and in vivo interactions of nitrovasodilators and zaprinast, a cGMP-selective phosphodiesterase inhibitor.
Merkel LA; Rivera LM; Perrone MH; Lappe RW
Eur J Pharmacol; 1992 May; 216(1):29-35. PubMed ID: 1326438
[TBL] [Abstract][Full Text] [Related]
27. Evidence that an L-arginine/nitric oxide dependent elevation of tissue cyclic GMP content is involved in depression of vascular reactivity by endotoxin.
Fleming I; Julou-Schaeffer G; Gray GA; Parratt JR; Stoclet JC
Br J Pharmacol; 1991 May; 103(1):1047-52. PubMed ID: 1678981
[TBL] [Abstract][Full Text] [Related]
28. Halothane attenuates nitric oxide relaxation of rat aortas by competition for the nitric oxide receptor site on soluble guanylyl cyclase.
Jing M; Ling GS; Bina S; Hart JL; Muldoon SM
Eur J Pharmacol; 1998 Jan; 342(2-3):217-24. PubMed ID: 9548389
[TBL] [Abstract][Full Text] [Related]
29. Cyclic GMP regulates cromakalim-induced relaxation in the rat aortic smooth muscle: role of cyclic GMP in K(ATP)-channels.
Wu CC; Chen SJ; Yen MH
Life Sci; 1999; 64(26):2471-8. PubMed ID: 10403506
[TBL] [Abstract][Full Text] [Related]
30. Evidence that different mechanisms underlie smooth muscle relaxation to nitric oxide and nitric oxide donors in the rabbit isolated carotid artery.
Plane F; Wiley KE; Jeremy JY; Cohen RA; Garland CJ
Br J Pharmacol; 1998 Apr; 123(7):1351-8. PubMed ID: 9579730
[TBL] [Abstract][Full Text] [Related]
31. Stimulation of soluble coronary arterial guanylate cyclase by SIN-1.
Schmidt K; Kukovetz WR
Eur J Pharmacol; 1986 Mar; 122(1):75-9. PubMed ID: 2869962
[TBL] [Abstract][Full Text] [Related]
32. [Mechanism of the vasodilating effect and blood platelet- antiaggregating activity of molsidomine and SIN-1].
Kukovetz WR; Holzmann S
Pathol Biol (Paris); 1987 Feb; 35(2 Pt 2):260-5. PubMed ID: 3031569
[TBL] [Abstract][Full Text] [Related]
33. Modulation of the pharmacological actions of nitrovasodilators by methylene blue and pyocyanin.
Gryglewski RJ; Zembowicz A; Salvemini D; Taylor GW; Vane JR
Br J Pharmacol; 1992 Aug; 106(4):838-45. PubMed ID: 1327388
[TBL] [Abstract][Full Text] [Related]
34. Role of the L-arginine-NO pathway and of cyclic GMP in electrical field-induced noradrenaline release and vasoconstriction in the rat tail artery.
Bucher B; Ouedraogo S; Tschöpl M; Paya D; Stoclet JC
Br J Pharmacol; 1992 Dec; 107(4):976-82. PubMed ID: 1334757
[TBL] [Abstract][Full Text] [Related]
35. Effect of in vivo nitroglycerin therapy on endothelium-dependent and independent vascular relaxation and cyclic GMP accumulation in rat aorta.
Molina CR; Andresen JW; Rapoport RM; Waldman S; Murad F
J Cardiovasc Pharmacol; 1987 Oct; 10(4):371-8. PubMed ID: 2444789
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of cyclic GMP-dependent protein kinase-mediated effects by (Rp)-8-bromo-PET-cyclic GMPS.
Butt E; Pöhler D; Genieser HG; Huggins JP; Bucher B
Br J Pharmacol; 1995 Dec; 116(8):3110-6. PubMed ID: 8719784
[TBL] [Abstract][Full Text] [Related]
37. A xanthine-based KMUP-1 with cyclic GMP enhancing and K(+) channels opening activities in rat aortic smooth muscle.
Wu BN; Lin RJ; Lin CY; Shen KP; Chiang LC; Chen IJ
Br J Pharmacol; 2001 Sep; 134(2):265-74. PubMed ID: 11564644
[TBL] [Abstract][Full Text] [Related]
38. Desensitization of guanylate cyclase in nitrate tolerance does not impair endothelium-dependent responses.
Mülsch A; Busse R; Bassenge E
Eur J Pharmacol; 1988 Dec; 158(3):191-8. PubMed ID: 2908105
[TBL] [Abstract][Full Text] [Related]
39. Exogenous GTP enhances sodium nitrite induced cyclic GMP accumulation in spontaneously beating rat atria.
Vuorinen P; Takalo R; Laustiola K; Manninen V; Vapaatalo H; Metsä-Ketelä T
Pharmacol Toxicol; 1991 Feb; 68(2):149-50. PubMed ID: 1649468
[No Abstract] [Full Text] [Related]
40. Studies of vascular tolerance to nitroglycerin: effects of N-acetylcysteine, NG-monomethyl L-arginine, and endothelin-1.
Lawson DL; Haught WH; Mehta P; Mehta JL
J Cardiovasc Pharmacol; 1996 Sep; 28(3):418-24. PubMed ID: 8877589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
